prepared to pay more but the move is moving forward. russia is accusing ukraine of trying to assassinate president vladimir putin and a drone attack on the kremlin. i would take anything coming out of the kremlin with a very large shaker of salt. norah: the immigration crisis at the southern border. why it is only expected to get worse. this is really not an impossible issue, it is an international, migration issue. u.s. citizens getting out of war-torn sudan. cbs news went aboard a saudi arabian navy ships sent to the african nation to evacuate refugees from the latest fighting. we are going back to america, and going to a safer place. baby norah: at the rock & roll hall of fame. is your favorite on the list of inductees? and if you want me then come on get me now norah: good evening, and thank you for joining us on this wednesday night. we begin with breaking news, and the urgent manhunt for a suspect accused of opening fire insid
allegations against cuomo. congressional and state leaders in his own party say cuomo can no longer govern effectively and should resign. cuomo remains steadfastly defiant saying in a teleconference friday that he is not going anywhere and he flat-out denies the allegations against him. i did not do what has been alleged. period. look, it s very simple, i never harassed anyone. i never abused anyone. i never assaulted anyone. now and i never would, right? i want to bring in new york assembly leader crystal stokes. so good that you could be with us. so what are your thoughts now about this newest allegation in the new york magazine from a political reporter who said that he behaved inappropriately around her? well, i think all of these women should be heard. they should have their due process much like i believe the governor should have his. when women complain people should listen, and i think we have set up a process in new york with the assembly judiciary committe
Amylyx Pharmaceuticals announced Thursday it was withdrawing its approved treatment against the deadly neurodegenerative disease ALS after clinical data found no evidence the drug worked. The news follows data from a clinical trial of 664 ALS patients announced in March, which found no significant differences in outcomes between those on the treatment group and those who received a placebo.
Roivant Sciences' experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm's.
Bristol Myers Squibb said on Thursday its experimental drug to treat Crohn's disease, a chronic inflammatory bowel condition, did not help patients achieve disease remission.